1,311
Views
11
CrossRef citations to date
0
Altmetric
Editorials

Idiopathic pulmonary fibrosis acute exacerbations: where are we now?

, , , &

References

  • Raghu G, Collard HR, Egan JJ, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824
  • Travis WD, Costabel U, Hansell DM, et al. ATS/ERS Committee on Idiopathic Interstitial Pneumonias.An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188(6):733-48
  • King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011;378(9807):1949-61
  • Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183(4):431-40
  • Martinez FJ, Safrin S, Weycker D, et al. IPF Study Group. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005;142(12 Pt 1):963-7
  • Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 1993;103:1808-12
  • Colby TV. Interstitial diseases. In: Colby TV, Lombard C, Yousem SA, Kitaichi M, editors. Atlas of pulmonary surgical pathology. WB Saunders Publishers; PA, USA: 1991. 227-306
  • Collard HR, Moore BB, Flaherty KR, et al. Idiopathic pulmonary fibrosis clinical research network investigators. acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007;176:636-43
  • Song JW, Hong SB, Lim CM, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 2011;37:356-63
  • Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J 2008;32:170-4
  • Araya J, Kawabata Y, Jinho P, et al. Clinically occult subpleural fibrosis and acute interstitial pneumonia a precursor to idiopathic pulmonary fibrosis? Respirology 2008;13:408-12
  • Bouros D, Nicholson AC, Polychronopoulos V, du Bois RM. Acute interstitial pneumonia. Eur Respir J 2000;15(2):412-18
  • Papiris SA, Manali ED, Kolilekas L, et al. IPF exacerbations: Unravelling Ariadne’s thread. Crit Care 2010;14(6):246
  • Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007;369:1553-65
  • Antoniou KM, Wells AU. Acute exacerbations of idiopathic pulmonary fibrosis. Respiration 2013;86(4):265-74
  • Huie TJ, Olson AL, Cosgrove GP, et al. A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes. Respirology 2010;15:909-17
  • Van der Eerden MM, Vlaspolder F, de Graaff CS, et al. Value of intensive diagnostic microbiological investigation in low and high risk patients with community acquired pneumonia. Eur J Clin Microb Infect Dis 2005;24:241-9
  • Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006;27:136-42
  • Sprung CL, Annane D, Keh D, et al.: for the CORTICUS Study Group Hydrocortisone Therapy for Patients with Septic Shock. N Engl J Med 2008;358:111-24
  • Sprung CL, Annane D, Singer M, et al.: for the CORTICUS Study Group. Glucocorticoids in sepsis: dissecting facts form fiction. Crit Care 2011;15:46
  • Mason PE, Khafaji AA, Milbrandt EB, et al. CORTICUS: The end of unconditional love for steroid use? Crit Care 2009;13:309
  • Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign guidelines committee including the pediatric subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 2013;39(2):165-228
  • The idiopathic pulmonary fibrosis clinical research network. Prednisone, azathioprine and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968-77
  • Papiris SA, Kagouridis K, Kolilekas L, et al. Survival in IPF acute exacerbations: the non-steroid approach. Presented at: European Respiratory Society Annual Congress. 7-11 September 2013; Barcelona, Spain
  • Papiris SA, Manali ED, Kolilekas L, et al. Steroids in idiopathic pulmonary fibrosis acute exacerbations: defenders or killers. Am J Respir Crit Care Med 2012;185(5):587-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.